X-P Phase 3 BRAND study
Phase 3
- Conditions
- ow Back Pain
- Registration Number
- JPRN-jRCT2080222337
- Lead Sponsor
- EAD CHEMICAL COMPANY, LIMITED
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 860
Inclusion Criteria
Patients with well-defined as low back pain and judged as suitable for NSAIDs treatment, etc.
Exclusion Criteria
Patients with symptom(s)/finding(s) falling under the contraindications or relative contraindications stated in the package insert for tablet, pap, tape and gel formulations of loxoprofen sodium, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy (pain assessment by patient)
- Secondary Outcome Measures
Name Time Method Efficacy (overall assessment)<br>Safety